Study on Evaluating the Effectiveness of Statins in the Treatment of Moyamoya Disease
ConditionMoyamoya Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorBeijing Tiantan Hospital
About this trial
The purpose of this study is to investigate the effectiveness of statins in the treatment of moyamoya disease based on multimodal magnetic resonance imaging.
Eligibility criteria
Qualifiers
The imaging examination meets the diagnostic criteria for moyamoya disease;
Sign the informed consent form;
Age ≥18 years old;
Baseline mRS score ≤2 points;
Disqualifiers
Patients with atherosclerosis, autoimmune diseases, meningitis, Down syndrome, cranial trauma, or those who have undergone radioactive head irradiation, as these conditions may lead to secondary cerebrovascular disease and contribute to the development of Moyamoya syndrome;
Individuals under the age of 18;
Participants who refuse to take part in this study;
Pregnant patients;
Trial design
Treatments tested in this trial
- Revascularization/Conservative management
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov